Filing Details

Accession Number:
0001562180-15-001020
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-02 15:01:03
Reporting Period:
2015-12-01
Filing Date:
2015-12-02
Accepted Time:
2015-12-02 15:01:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1557883 Dermira Inc. DERM Pharmaceutical Preparations (2834) 273267680
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1210524 A Eugene Bauer C/O Dermira, Inc.
275 Middlefield Road, Suite 150
Menlo Park CA 94025
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-12-01 1,379 $29.07 75,599 No 4 S Indirect By the Bauer Family 1995 Trust
Common Stock Disposition 2015-12-01 921 $30.29 74,678 No 4 S Indirect By the Bauer Family 1995 Trust
Common Stock Disposition 2015-12-01 200 $30.70 74,478 No 4 S Indirect By the Bauer Family 1995 Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By the Bauer Family 1995 Trust
No 4 S Indirect By the Bauer Family 1995 Trust
No 4 S Indirect By the Bauer Family 1995 Trust
Footnotes
  1. These trades were made pursuant to a Rule 10b5-1 trading plan.
  2. This transaction was executed in multiple trades at prices ranging from $28.42 to $29.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The Reporting Person is a Co-Trustee.
  4. This transaction was executed in multiple trades at prices ranging from $29.57 to $30.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. These trades were made pursuant to a Rule 10b5-1 trading plan.
  6. This transaction was executed in multiple trades at prices ranging from $30.60 to $30.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.